SEC v. Caroline J. Campbell (insider trading, 2026)

Settled

✓ Checked against the primary document on October 3, 2026. The library's summary, tags and figures for this record were compared with the regulator's own document by an AI model (Claude) following written instructions, with sampled and disputed records read a second time. No lawyer has reviewed them. A checked record can still contain errors, and checked does not mean endorsed. See how we check records or report a correction.

Report an error in this record (sec-caroline-j-campbell-insider-trading-2026) by email

In April 2026 the Securities and Exchange Commission settled with Caroline Campbell, an ImmunityBio employee, finding that she placed orders on May 9 and 10, 2023 to sell 48,495 shares on knowledge that the FDA would delay approval of Anktiva, avoiding losses of $157,066.28 when the stock fell about 55 percent. She agreed to a cease-and-desist order, $157,066.28 in disgorgement, $18,130.97 in interest and an equal penalty, payable in instalments.

The record

What was ordered

Civil penalty

$157k

Disgorgement

$157k

Prejudgment interest

$18.1k

Total relief

$332k

Alleged gain

$157k

A dash means the release did not state a figure we could extract, not that the figure is zero. Penalty and disgorgement are stored separately so aggregates across the library do not double-count the same dollars.

What is alleged to have happened

The Securities and Exchange Commission issued this settled order on April 6, 2026 (Release No. 34-105151).

The order finds she breached a duty of trust and confidence owed to ImmunityBio. A parallel order covers another ImmunityBio employee.

For the regulator's own account of the facts, read the primary document linked above. This page deliberately summarises the structured record rather than reproducing the release.

What technique is this, and how does it work?

This action is tagged with one technique in our taxonomy. The tagging is ours: regulators charge statutory provisions, not technique names, so the mapping is an editorial judgement described in our editorial policy.

• Insider trading — see how it works, what statute it engages, and every other action tagged the same way.

Timeline

1. 2026-04-06 Administrative proceeding instituted (cease-and-desist)

Primary documents

Everything on this page derives from the documents below. Where our summary and the primary document disagree, the primary document is right.

• SEC order

The linked release is a work of the United States government and is not subject to copyright. Our summary and narrative above are our own writing.

Related actions

Other actions in the library sharing at least one technique tag with this one.

Record added September 10, 2026. submit a correction.